BioSpace News Archive

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its second quarter ended June 30, 2022.

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported financial results and business highlights for the second quarter ended June 30, 2022.

Travere Therapeutics, Inc. provided regulatory updates for its sparsentan programs in IgA nephropathy and focal segmental glomerulosclerosis, as well as its pegtibatinase program for classical homocystinuria.

Amgen announced that its Board of Directors declared a $1.94 per share dividend for the third quarter of 2022.

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced second quarter 2022 financial results.

Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, reported the grant of an aggregate of 22,200 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 44,500 shares of Arcutis’ common stock to five newly hired employees.

Ascletis Pharma Inc. announces that the Investigational New Drug application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase for COVID-19, has been accepted by China National Medical Products Administration.

Corcept Therapeutics Incorporated, a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol, reported its results for the quarter ended June 30, 2022.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, reported second quarter 2022 financial results and provided a corporate update.

Kiniksa Pharmaceuticals, Ltd. announced that its management will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Conference on Tuesday, August 9, 2022 at 2:55 p.m. Eastern Time.